Clorox (CLX) Liabilities and Shareholders Equity (2009 - 2026)

Clorox's Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $6.4 billion for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 16.76% year-over-year to $6.4 billion in Q1 2026; TTM through Mar 2026 was $23.1 billion, a 3.59% increase from a year earlier, with the FY2025 full-year figure at $5.6 billion, down 3.3% from the prior year.
• Liabilities and Shareholders Equity grew to $6.4 billion in Q1 2026 per CLX's latest filing, from $5.6 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $6.4 billion in Q1 2026 and bottomed at $5.5 billion in Q3 2024.
• The 5-year median for Liabilities and Shareholders Equity is $5.8 billion (2023), against an average of $5.9 billion.
• Across the five-year window, Liabilities and Shareholders Equity retreated 8.25% in 2024 and grew 16.76% in 2026, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $6.0 billion in 2022, then slipped by 2.27% to $5.9 billion in 2023, then declined by 5.6% to $5.6 billion in 2024, then climbed by 0.65% to $5.6 billion in 2025, then grew by 14.66% to $6.4 billion in 2026.
• Per Business Quant, the three latest CLX Liabilities and Shareholders Equity figures stand at $6.4 billion (Q1 2026), $5.6 billion (Q4 2025), and $5.5 billion (Q3 2025).